Tweedle M F, Eaton S M, Eckelman W C, Gaughan G T, Hagan J J, Wedeking P W, Yost F J
Squibb Institute for Medical Research, New Brunswick, NJ 08903.
Invest Radiol. 1988 Sep;23 Suppl 1:S236-9. doi: 10.1097/00004424-198809001-00049.
The blood clearance kinetics of five gadolinium complexes, Gd(L), were determined in rats and the results interpreted in terms of an open two-compartment pharmacokinetic model. The complexes were tested in vitro for stability in serum and in aqueous solutions of ions that they might encounter in vivo and that might be expected to react with the Gd(L) complexes to produce uncomplexed gadolinium. Reaction with serum was observed in two instances. Chemical structural differences among the chelating ligands appear to govern the overall reactivity of their Gd(L) complexes. It may be inferred from the results that a preferred structural feature of the ligand is the presence of a 12-membered 1,4,7,10-tetraaza macrocycle.
在大鼠体内测定了五种钆配合物Gd(L)的血液清除动力学,并根据开放的二室药代动力学模型对结果进行了解释。对这些配合物进行了体外测试,以考察它们在血清以及它们在体内可能遇到的、预期会与Gd(L)配合物反应生成未配位钆的离子水溶液中的稳定性。在两种情况下观察到了与血清的反应。螯合配体之间的化学结构差异似乎决定了其Gd(L)配合物的整体反应活性。从结果可以推断,配体的一个优选结构特征是存在一个12元的1,4,7,10-四氮杂大环。